Fulgent Therapeutics Revenue, Growth & Competitor Profile

DBA FULGENT DIAGNOSTICS

Company Profile & Annual Report for Fulgent Therapeutics

Access the complete profile.

Fulgent Therapeutics Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	500 - 1,000Exact Company Size
Primary Industry	812 Personal & Laundry Services
Additional NAICS Codes	621511 Medical Laboratories
Address	4399 Santa Anita Ave El Monte, CA 91731

Note: Revenues for privately held companies are statistical evaluations.


Fulgent Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Fulgent Therapeutics's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Fulgent Therapeutics is classified as operating in the Personal & Laundry Services industry, NAICS Code 812.

Fulgent Therapeutics Annual Revenue and Growth Rate

Fulgent Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Fulgent Therapeutics's revenues are gauged from an analysis of company filings.

Fulgent Therapeutics's Income Statement (based on Industry Averages)

Fulgent Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Fulgent Therapeutics is developing and marketing. Fulgent Therapeutics doesn't have any recent trademark applications, indicating Fulgent Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
FULGENT ONCOLOGY Testing for medical diagnostic and treatment purposes, namely, pathology, genetic, and molecular medical testing for cancer and other cancer diagnostic, monitoring, and detection for medical diagnostic and treatment purposes	07/12/2022
FULGENT Genetic testing for medical purposes	07/01/2016

See all trademarks and details in the Full Report.

Market Share of Fulgent Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Fulgent Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
CINTAS	Mason, OH	100
UPBOUND GROUP	Plano, TX	85
DENTAL EXPRESS STAFFING	Wilton, WI	59
SCI SHARED RESOURCES	Houston, TX	53
TEAM PUBLIC CHOICES	San Diego, CA	50
UNIFIRST	Richmond, VA	47
TRION SOLUTIONS	Troy, MI	45
SERVICE CORPORATION INTERNATIONAL	Houston, TX	40
PLUS COMPANY U.S.	San Francisco, CA	33

Nearby Competitors

These companies are similar in business line and location to Fulgent Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
FULGENT THERAPEUTICS	El Monte, CA	100
MISSION LINEN SUPPLY	Chino, CA	89
INCOME PROPERTY INVESTMENTS IN	Rancho Cucamonga, CA	51
GOLDEN STAR PACIFIC	South El Monte, CA	18
GUARD-SYSTEMS	Monterey Park, CA	13
POSITIVE BEHAVIOR STEPS CORPOR	West Covina, CA	8

Future Competition: Fulgent Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Fulgent Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)